{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:23:10Z","timestamp":1790518990768,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T00:00:00Z","timestamp":1631664000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T00:00:00Z","timestamp":1631664000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Leishmaniases are regularly seen in non-endemic areas due to the increase of international travels. They include cutaneous leishmaniases (CL) and mucocutaneous (MC) caused by different <jats:italic>Leishmania<\/jats:italic> species, and visceral leishmaniases (VL) which present with non-specific symptoms.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We reviewed all consecutive leishmaniasis cases seen between September 2012 and May 2020. The diagnostic strategy included microscopy after May-Gr\u00fcnwald-Giemsa staining, a diagnostic quantitative PCR (qPCR) assay, and species identification based on sequencing of the cytochrome <jats:italic>b<\/jats:italic> gene.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Eighty-nine patients had a definitive leishmaniasis diagnosis. Nine patients had VL with <jats:italic>Leishmania infantum<\/jats:italic>. Eighty patients had CL. Twelve patients acquired CL after trips in Latin America (7 <jats:italic>Leishmania guyanensis<\/jats:italic>, 2 <jats:italic>Leishmania braziliensis<\/jats:italic>, 2 <jats:italic>Leishmania mexicana<\/jats:italic>, and 1 <jats:italic>Leishmania panamensis<\/jats:italic>). Species could be identified in 63 of the 68 CLs mainly after travel in North Africa (59%) with <jats:italic>Leishmania major<\/jats:italic> (65%), <jats:italic>Leishmania tropica\/killicki<\/jats:italic> (24%), and <jats:italic>L. infantum<\/jats:italic> (11%), or in West Sub-Saharan Africa (32%), all due to <jats:italic>L. major<\/jats:italic>. The median day between appearance of the lesions and diagnosis was 90 [range 60\u2013127].<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our diagnostic strategy allows both positive diagnoses and species identifications. Travelers in West Sub-Saharan Africa and North Africa should be better aware of the risk of contracting leishmananiasis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-021-06631-5","type":"journal-article","created":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T04:05:04Z","timestamp":1631678704000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Imported leishmaniasis in travelers: a 7-year retrospective from a Parisian hospital in France"],"prefix":"10.1186","volume":"21","author":[{"given":"Nesrine","family":"Aissaoui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samia","family":"Hamane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maud","family":"Gits-Muselli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Petit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mazouz","family":"Benderdouche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blandine","family":"Denis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Alanio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Delli\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Bagot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Bretagne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,15]]},"reference":[{"key":"6631_CR1","doi-asserted-by":"publisher","first-page":"489","DOI":"10.4269\/ajtmh.15-0408","volume":"94","author":"I Okwor","year":"2016","unstructured":"Okwor I, Uzonna J. Social and economic burden of human leishmaniasis. Am J Trop Med Hyg. 2016;94:489\u201393.","journal-title":"Am J Trop Med Hyg"},{"key":"6631_CR2","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/S1473-3099(16)30217-1","volume":"17","author":"C Karimkhani","year":"2017","unstructured":"Karimkhani C, Wanga V, Naghavi P, Dellavalle RP, Naghavi M. Global burden of cutaneous leishmaniasis. Lancet Infect Dis. 2017;17:264.","journal-title":"Lancet Infect Dis"},{"key":"6631_CR3","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1051\/parasite\/2014014","volume":"21","author":"K Aoun","year":"2014","unstructured":"Aoun K, Bouratbine A. Cutaneous leishmaniasis in North Africa: a review. Parasite. 2014;21:14.","journal-title":"Parasite."},{"key":"6631_CR4","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S0140-6736(18)31204-2","volume":"392","author":"S Burza","year":"2018","unstructured":"Burza S, Croft SL, Boelaert M. Leishmaniasis. Lancet. 2018;392:951\u201370.","journal-title":"Lancet"},{"key":"6631_CR5","doi-asserted-by":"crossref","unstructured":"Hodiamont CJ, Kager PA, Bart A, de Vries HJC, van Thiel PPAM, Leenstra T, et al. Species-directed therapy for leishmaniasis in returning travellers: a comprehensive guide. Ghedin E, editor. PLoS Negl Trop Dis. 2014;8:e2832.","DOI":"10.1371\/journal.pntd.0002832"},{"key":"6631_CR6","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/jtm.12089","volume":"21","author":"J Blum","year":"2014","unstructured":"Blum J, Buffet P, Visser L, Harms G, Bailey MS, Caumes E, et al. LeishMan recommendations for treatment of cutaneous and mucosal leishmaniasis in travelers, 2014. J Travel Med. 2014;21:116\u201329.","journal-title":"J Travel Med"},{"key":"6631_CR7","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.tmaid.2014.09.007","volume":"12","author":"P Mansueto","year":"2014","unstructured":"Mansueto P, Seidita A, Vitale G, Cascio A. Leishmaniasis in travelers: a literature review. Travel Med Infect Dis. 2014;12:563\u201381.","journal-title":"Travel Med Infect Dis"},{"key":"6631_CR8","doi-asserted-by":"publisher","first-page":"e1032","DOI":"10.1016\/j.ijid.2010.06.019","volume":"14","author":"A Pavli","year":"2010","unstructured":"Pavli A, Maltezou HC. Leishmaniasis, an emerging infection in travelers. Int J Infect Dis. 2010;14:e1032\u20139.","journal-title":"Int J Infect Dis"},{"key":"6631_CR9","doi-asserted-by":"publisher","first-page":"e1032","DOI":"10.1093\/jtm\/tay117","volume":"26","author":"AK Boggild","year":"2019","unstructured":"Boggild AK, Caumes E, Grobusch MP, Schwartz E, Hynes NA, Libman M, et al. Cutaneous and mucocutaneous leishmaniasis in travellers and migrants: a 20-year GeoSentinel Surveillance Network analysis. J Travel Med. 2019;26:e1032.","journal-title":"J Travel Med."},{"key":"6631_CR10","doi-asserted-by":"publisher","first-page":"20534","DOI":"10.2807\/1560-7917.ES2013.18.29.20534","volume":"18","author":"L Lachaud","year":"2013","unstructured":"Lachaud L, Dedet JP, Marty P, Faraut F, Buffet P, Gangneux J-P, et al. Surveillance of leishmaniases in France, 1999 to 2012. Eurosurveillance. 2013;18:20534.","journal-title":"Eurosurveillance"},{"key":"6631_CR11","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1128\/JCM.02555-06","volume":"45","author":"F Foulet","year":"2007","unstructured":"Foulet F, Botterel F, Buffet P, Morizot G, Rivollet D, Deniau M, et al. Detection and identification of Leishmania species from clinical specimens by using a real-time PCR assay and sequencing of the cytochrome B gene. J Clin Microbiol. 2007;45:2110\u20135.","journal-title":"J Clin Microbiol"},{"key":"6631_CR12","doi-asserted-by":"publisher","first-page":"24","DOI":"10.4269\/ajtmh.16-84256","volume":"96","author":"N Aronson","year":"2017","unstructured":"Aronson N, Herwaldt BL, Libman M, Pearson R, L\u00f3pez-V\u00e9lez R, Weina P, et al. Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH). Am J Trop Med Hyg. 2017;96:24\u201345.","journal-title":"Am J Trop Med Hyg."},{"key":"6631_CR13","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1093\/mmy\/myu087","volume":"53","author":"N Guigue","year":"2015","unstructured":"Guigue N, Alanio A, Menotti J, Castro ND, Hamane S, Peyrony O, et al. Utility of adding Pneumocystis jirovecii DNA detection in nasopharyngeal aspirates in immunocompromised adult patients with febrile pneumonia. Med Mycol. 2015;53:241\u20137.","journal-title":"Med Mycol"},{"key":"6631_CR14","doi-asserted-by":"crossref","unstructured":"Mesa LE, Manrique R, Muskus C, Robledo SM. Test accuracy of polymerase chain reaction methods against conventional diagnostic techniques for Cutaneous Leishmaniasis (CL) in patients with clinical or epidemiological suspicion of CL: systematic review and meta-analysis. Chatterjee M, editor. PLoS Negl Trop Dis. Public Library of Science; 2020;14:e0007981.","DOI":"10.1371\/journal.pntd.0007981"},{"key":"6631_CR15","doi-asserted-by":"publisher","first-page":"107773","DOI":"10.1016\/j.exppara.2019.107773","volume":"207","author":"CC Conter","year":"2019","unstructured":"Conter CC, Mota CA, Dos Santos BA, de Braga SL, de Terron SM, Navasconi TR, et al. PCR primers designed for new world Leishmania: a systematic review. Exp Parasitol. 2019;207:107773.","journal-title":"Exp. Parasitol."},{"key":"6631_CR16","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.cccn.2005.05.051","volume":"363","author":"S Bretagne","year":"2006","unstructured":"Bretagne S, Costa J-M. Towards a nucleic acid-based diagnosis in clinical parasitology and mycology. Clin Chim Acta. 2006;363:221\u20138.","journal-title":"Clin Chim Acta"},{"key":"6631_CR17","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1017\/S0031182004004792","volume":"128","author":"GE Luyo-Acero","year":"2004","unstructured":"Luyo-Acero GE, Uezato H, Oshiro M, Takei K, Kariya K, Katakura K, et al. Sequence variation of the cytochrome b gene of various human infecting members of the genus Leishmania and their phylogeny. Parasitology. 2004;128:483\u201391.","journal-title":"Parasitology"},{"key":"6631_CR18","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1186\/1756-3305-7-420","volume":"7","author":"T Mouttaki","year":"2014","unstructured":"Mouttaki T, Morales-Yuste M, Merino-Espinosa G, Chiheb S, Fellah H, Martin-Sanchez J, et al. Molecular diagnosis of cutaneous leishmaniasis and identification of the causative Leishmania species in Morocco by using three PCR-based assays. Parasit Vectors. 2014;7:420\u20139.","journal-title":"Parasit Vectors"},{"key":"6631_CR19","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.actatropica.2012.01.014","volume":"122","author":"K Jaouadi","year":"2012","unstructured":"Jaouadi K, Depaquit J, Haouas N, Chaara D, Gorcii M, Chargui N, et al. Twenty-four new human cases of cutaneous leishmaniasis due to Leishmania killicki in Metlaoui, southwestern Tunisia: probable role of Phlebotomus sergenti in the transmission. Acta Trop. 2012;122:276\u201383.","journal-title":"Acta Trop"},{"key":"6631_CR20","doi-asserted-by":"crossref","unstructured":"Srivastava P, Mehrotra S, Tiwary P, Chakravarty J, Sundar S. Diagnosis of Indian visceral leishmaniasis by nucleic acid detection using PCR. Snounou G, editor. PLoS ONE; 2011;6:e19304.","DOI":"10.1371\/journal.pone.0019304"},{"key":"6631_CR21","doi-asserted-by":"crossref","unstructured":"Fletcher K, Issa R, Lockwood DNJ. Visceral leishmaniasis and immunocompromise as a risk factor for the development of visceral leishmaniasis: a changing pattern at the hospital for tropical diseases, london. Schallig HDFH, editor. PLoS ONE. Public Library of Science; 2015;10:e0121418.","DOI":"10.1371\/journal.pone.0121418"},{"key":"6631_CR22","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1186\/s13071-019-3628-z","volume":"12","author":"L Horrillo","year":"2019","unstructured":"Horrillo L, Castro A, Mat\u00eda B, Molina L, Garc\u00eda-Mart\u00ednez J, Jaqueti J, et al. Clinical aspects of visceral leishmaniasis caused by L. infantum in adults. Ten years of experience of the largest outbreak in Europe: what have we learned? Parasit Vectors. 2019;12:359\u201311.","journal-title":"Parasit Vectors."},{"key":"6631_CR23","doi-asserted-by":"publisher","first-page":"e28","DOI":"10.1590\/s1678-9946202062028","volume":"62","author":"PS Kurizky","year":"2020","unstructured":"Kurizky PS, Marianelli FF, Cesetti MV, Damiani G, Sampaio RNR, Gon\u00e7alves LMT, et al. A comprehensive systematic review of leishmaniasis in patients undergoing drug-induced immunosuppression for the treatment of dermatological, rheumatological and gastroenterological diseases. Rev Inst Med Trop Sao Paulo. 2020;62:e28.","journal-title":"Rev Inst Med Trop Sao Paulo."},{"key":"6631_CR24","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1136\/ard.2010.137422","volume":"70","author":"D Salmon-Ceron","year":"2011","unstructured":"Salmon-Ceron D, Tubach F, Lortholary O, Chosidow O, Bretagne S, Nicolas N, et al. Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry. Ann Rheum Dis. 2011;70:616\u201323.","journal-title":"Ann Rheum Dis"},{"key":"6631_CR25","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S1473-3099(08)70043-4","volume":"8","author":"S Antinori","year":"2008","unstructured":"Antinori S, Cascio A, Parravicini C, Bianchi R, Corbellino M. Leishmaniasis among organ transplant recipients. Lancet Infect Dis. 2008;8:191\u20139.","journal-title":"Lancet Infect Dis"},{"key":"6631_CR26","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.jiac.2018.05.008","volume":"24","author":"P Tatarelli","year":"2018","unstructured":"Tatarelli P, Fornaro G, Del Bono V, Nicolini LA, Raiola AM, Gualandi F, et al. Visceral leishmaniasis in hematopoietic cell transplantation: case report and review of the literature. J Infect Chemother. 2018;24:990\u20134.","journal-title":"J Infect Chemother"},{"key":"6631_CR27","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1111\/j.1462-5822.2008.01146.x","volume":"10","author":"C Bogdan","year":"2008","unstructured":"Bogdan C. Mechanisms and consequences of persistence of intracellular pathogens: leishmaniasis as an example. Cell Microbiol. 2008;10:1221\u201334.","journal-title":"Cell Microbiol."},{"key":"6631_CR28","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1111\/bjd.18262","volume":"181","author":"PS Kurizky","year":"2019","unstructured":"Kurizky PS, Gomes CM, Cesetti MV, Martins GA, Regattieri NAT, Marianelli FF, et al. Cross-sectional screening study for Leishmania DNA and antibodies in biologic-treated patients with psoriasis living in an area endemic for leishmaniasis. Br J Dermatol. 2019;181:1337\u20139.","journal-title":"Br J Dermatol."},{"key":"6631_CR29","first-page":"59","volume":"3","author":"K-L Koster","year":"2015","unstructured":"Koster K-L, Laws H-J, Troeger A, Meisel R, Borkhardt A, Oommen PT. Visceral Leishmaniasis as a possible reason for pancytopenia. Front Pediatr Frontiers. 2015;3:59.","journal-title":"Front Pediatr Frontiers."},{"key":"6631_CR30","doi-asserted-by":"publisher","first-page":"104855","DOI":"10.1016\/j.actatropica.2018.12.010","volume":"197","author":"A Schwing","year":"2019","unstructured":"Schwing A, Pomares C, Majoor A, Boyer L, Marty P, Michel G. Leishmania infection: misdiagnosis as cancer and tumor-promoting potential. Acta Trop. 2019;197:104855.","journal-title":"Acta Trop."},{"key":"6631_CR31","first-page":"e35671","volume":"3","author":"DM Pigott","year":"2014","unstructured":"Pigott DM, Bhatt S, Golding N, Duda KA, Battle KE, Brady OJ, et al. Global distribution maps of the leishmaniases. Elife. 2014;3:e35671.","journal-title":"Elife"},{"key":"6631_CR32","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1186\/s12879-020-05529-y","volume":"20","author":"CA Correa-C\u00e1rdenas","year":"2020","unstructured":"Correa-C\u00e1rdenas CA, P\u00e9rez J, Patino LH, Ram\u00edrez JD, Duque MC, Romero Y, et al. Distribution, treatment outcome and genetic diversity of Leishmania species in military personnel from Colombia with cutaneous leishmaniasis. BMC Infect Dis. 2020;20:938\u20131011.","journal-title":"BMC Infect Dis"},{"key":"6631_CR33","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.4269\/ajtmh.2010.10-0234","volume":"83","author":"N Bousslimi","year":"2010","unstructured":"Bousslimi N, Aoun K, Ben-Abda I, Ben-Alaya-Bouafif N, Raouane M, Bouratbine A. Epidemiologic and clinical features of cutaneous leishmaniasis in southeastern Tunisia. Am J Trop Med Hyg. 2010;83:1034\u20139.","journal-title":"Am J Trop Med Hyg."},{"key":"6631_CR34","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s40249-018-0413-8","volume":"7","author":"T Mouttaki","year":"2018","unstructured":"Mouttaki T, Maksouri H, El Mabrouki J, Merino-Espinosa G, Fellah H, Itri M, et al. Concomitant visceral and localized cutaneous leishmaniasis in two Moroccan infants. Infect Dis Poverty. 2018;7:32\u20135.","journal-title":"Infect Dis Poverty"},{"key":"6631_CR35","doi-asserted-by":"crossref","unstructured":"Mandell MA, Beverley SM. Concomitant immunity induced by persistent leishmania major does not preclude secondary re-infection: implications for genetic exchange, diversity and vaccination. Debrabant A, editor. PLoS Negl Trop Dis. 2016;10:e0004811.","DOI":"10.1371\/journal.pntd.0004811"},{"key":"6631_CR36","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.3390\/ijerph15071542","volume":"15","author":"K Kholoud","year":"2018","unstructured":"Kholoud K, Denis S, Lahouari B, El Hidan MA, Souad B. Management of Leishmaniases in the era of climate change in Morocco. Int J Environ Res Public Health. 2018;15:1542.","journal-title":"Int J Environ Res Public Health."},{"key":"6631_CR37","doi-asserted-by":"crossref","unstructured":"Sunyoto T, Verdonck K, Safi El S, Potet J, Picado A, Boelaert M. Uncharted territory of the epidemiological burden of cutaneous leishmaniasis in sub-Saharan Africa-A systematic review. Louzir H, editor. PLoS Negl Trop Dis. 2018;12:e0006914.","DOI":"10.1371\/journal.pntd.0006914"},{"key":"6631_CR38","doi-asserted-by":"crossref","unstructured":"Traor\u00e9 B, Oliveira F, Faye O, Dicko A, Coulibaly CA, Sissoko IM, et al. Prevalence of cutaneous leishmaniasis in districts of high and low endemicity in Mali. Boelaert M, editor. PLoS Negl Trop Dis. 2016;10:0005141.","DOI":"10.1371\/journal.pntd.0005141"},{"key":"6631_CR39","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1111\/j.1365-3156.2009.02336.x","volume":"14","author":"F Pratlong","year":"2009","unstructured":"Pratlong F, Dereure J, Ravel C, Lami P, Balard Y, Serres G, et al. Geographical distribution and epidemiological features of Old World cutaneous leishmaniasis foci, based on the isoenzyme analysis of 1048 strains. Trop Med Int Health. 2009;14:1071\u201385.","journal-title":"Trop Med Int Health."},{"key":"6631_CR40","first-page":"251","volume":"66","author":"A Zida","year":"2020","unstructured":"Zida A, Sangar\u00e9 I, Nezien D, Bretagne S, Bamba S, Deniau M, et al. Mastomys natalensis, Cricetomys gambianus and Taterillus sp. were found PCR positive for Leishmania major in Burkina Faso, West Africa. Ann Parasitol. 2020;66:251\u20134.","journal-title":"Ann Parasitol."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-06631-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-021-06631-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-06631-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T04:06:02Z","timestamp":1631678762000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-021-06631-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,15]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["6631"],"URL":"https:\/\/doi.org\/10.1186\/s12879-021-06631-5","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,15]]},"assertion":[{"value":"10 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This was a retrospective non-interventional analysis that had no impact on standard clinical procedures and no additional biological sampling following the physicians\u2019 prescriptions for optimal treatment. Clinical data were anonymized before the analysis. French Health Public Law (CSP Art L1121\u20131.1) states that such a protocol does not require ethical approval and is exempt from informed consent procedures. All methods were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Signed informed consent was obtained for the photographs.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors report no conflicts of interest. The authors alone are responsible for the content and the writing of the paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"953"}}